Robert D. Dillard

1.2k citations

39 papers · 980 indexed · h-index 16

Impact in

Organic Chemistry top 5%
- Catalytic C–H Functionalization Methods
- Synthesis and biological activity
- Synthesis and Catalytic Reactions
- Sulfur-Based Synthesis Techniques
Molecular Biology
- Protein Kinase Regulation and GTPase Signaling
- Receptor Mechanisms and Signaling
- Chemical Synthesis and Analysis

Papers in ⓘ

Organic Chemistry 28
- Synthesis and Reactions of Organic Compounds 7
- Synthesis of heterocyclic compounds 5
- Synthesis and Characterization of Pyrroles 5
- Carbohydrate Chemistry and Synthesis 4
- Asymmetric Synthesis and Catalysis 3
Molecular Biology 15
- Protein Kinase Regulation and GTPase Signaling 7
- Chemical Synthesis and Analysis 4

Co-authors: Nelson R. Easton (17 shared papers)Nicholas J. Bach (8 shared papers)David W. Snyder (9 shared papers)Susan E. Draheim (8 shared papers)Lawrence W. Hartley (7 shared papers)Edward D. Mihelich (7 shared papers)Cynthia D. Sommers (5 shared papers)Richard W. Schevitz (5 shared papers)
Journals: The Journal of Organic Chemistry (12 papers)Journal of Medicinal Chemistry (11 papers)Journal of Pharmacology and Experimental Therapeutics (6 papers)Toxicology and Applied Pharmacology (2 papers)Tetrahedron Letters (1 paper)
Partner nations: United States

In The Last Decade

Robert D. Dillard

39 papers receiving 946 citations

Peers

Countries citing papers authored by Robert D. Dillard

Since Specialization

Citations

This map shows the geographic impact of Robert D. Dillard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert D. Dillard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert D. Dillard more than expected).

Fields of papers citing papers by Robert D. Dillard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert D. Dillard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert D. Dillard. The network helps show where Robert D. Dillard may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert D. Dillard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert D. Dillard Line = papers co-authored together Robert D. Dillard links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure-based design of the first potent and selective inhibitor of human non-pancreatic secretory phospholipase A2 Nature Structural & Molecular Biology ·Richard W. Schevitz, Nicholas J. Bach, D. G. CARLSON, Nickolay Y. Chirgadze, David K. Clawson, Robert D. Dillard, Susan E. Draheim, Lawrence W. Hartley, N.D. Jones, Edward D. Mihelich, Jennifer L. Olkowski, David W. Snyder, Cynthia D. Sommers, Jean‐Pierre Wery	1995	188
2	Synthesis and antiinflammatory activity of some 2,2-dimethyl-1,2-dihydroquinolines Journal of Medicinal Chemistry ·Robert D. Dillard, D. E. Pavey, D. N. Benslay	1973	123
3	Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 3. Indole-3-glyoxamides Journal of Medicinal Chemistry ·Susan E. Draheim, Nicholas J. Bach, Robert D. Dillard, Dennis R. Berry, Donald G. Carlson, Nickolay Y. Chirgadze, David K. Clawson, Lawrence W. Hartley, Lea M. Johnson, Noel D. Jones, Emma R. McKinney, Edward D. Mihelich, Jennifer L. Olkowski, Richard W. Schevitz, Amy C. Smith, David W. Snyder, Cynthia D. Sommers, Jean‐Pierre Wery	1996	76
4	Pharmacology of LY315920/S-5920, [[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1 H-indol-4-yl]oxy]acetate, a Potent and Selective Secretory Phospholipase A2Inhibitor: A New Class of Anti-Inflammatory Drugs, SPI Journal of Pharmacology and Experimental Therapeutics ·David W. Snyder, Nicholas J. Bach, Robert D. Dillard, Susan E. Draheim, Donald G. Carlson, Niles Fox, Neal W. Roehm, Christopher T. Armstrong, C. Chang, Lawrence W. Hartley, Lea M. Johnson, Carlos Romero, Amy C. Smith, Min Song, Jerome H. Fleisch	1999	70
5	Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 1. Indole-3-acetamides Journal of Medicinal Chemistry ·Robert D. Dillard, Nicholas J. Bach, Susan E. Draheim, Dennis R. Berry, Donald G. Carlson, Nickolay Y. Chirgadze, David K. Clawson, Lawrence W. Hartley, Lea M. Johnson, Noel D. Jones, Emma R. McKinney, Edward D. Mihelich, Jennifer L. Olkowski, Richard W. Schevitz, Amy C. Smith, David W. Snyder, Cynthia D. Sommers, Jean‐Pierre Wery	1996	64
6	Synthesis and blood pressure lowering activity of 3-(substituted-amino)-1,2,4-benzothiadiazine 1-oxide derivatives Journal of Medicinal Chemistry ·Robert D. Dillard, Terence T. Yen, Paul Stark, D. E. Pavey	1980	60
7	Indole Inhibitors of Human Nonpancreatic Secretory Phospholipase A₂. 2. Indole-3-acetamides with Additional Functionality Journal of Medicinal Chemistry ·Robert D. Dillard, Nicholas J. Bach, Susan E. Draheim, Dennis R. Berry, Donald G. Carlson, Nickolay Y. Chirgadze, David K. Clawson, Lawrence W. Hartley, Lea M. Johnson, Noel D. Jones, Emma R. McKinney, Edward D. Mihelich, Jennifer L. Olkowski, Richard W. Schevitz, Amy C. Smith, David W. Snyder, Cynthia D. Sommers, Jean‐Pierre Wery	1996	35
8	Transgenic model for the discovery of novel human secretory non-pancreatic phospholipase A2 inhibitors European Journal of Pharmacology ·Niles Fox, Min Song, James Schrementi, John Sharp, D. L. White, David W. Snyder, Lawrence W. Hartley, Donald G. Carlson, Nicholas J. Bach, Robert D. Dillard, Susan E. Draheim, Jesse L. Bobbitt, Lawrence F. Fisher, Edward D. Mihelich	1996	32
9	Induction of peroxisomal β-oxidation in the rat liver in vivo and in vitro by tetrazole-substituted acetophenones: Structure-activity relationships Toxicology and Applied Pharmacology ·Patrick I. Eacho, Patricia Foxworthy, Robert D. Dillard, Celia A. Whitesitt, David K. Herron, Winston S. Marshall	1989	29
10	Reactions of Acetylenic Amines. VIII. Cyclization of Acetylenic Ureas The Journal of Organic Chemistry ·Nelson R. Easton, Donald R. Cassady, Robert D. Dillard	1964	28
11	Receptor interactrions of imidazolines. VI. Significance of carbon bridge separating phenyl and imidazoline rings of tolazoline-like alpha adrenergic imidazolines. Journal of Pharmacology and Experimental Therapeutics ·R R Ruffolo, E L Yaden, J E Waddell, Robert D. Dillard	1980	27
12	Reactions of Acetylenes. I. t-Ethynyl Alcohol with Isocyanates The Journal of Organic Chemistry ·Nelson R. Easton, Donald R. Cassady, Robert D. Dillard	1962	25
13	Pulmonary gas trapping in the guinea pig and its application in pharmacological testing Journal of Pharmacological Methods ·Steven A. Silbaugh, Peter W. Stengel, Robert D. Dillard, Kerry G. Bemis	1987	23
14	Receptor interactions of imidazolines. II. Affinities and efficacies of hydroxy-substituted tolazoline derivatives in rat aorta. Journal of Pharmacology and Experimental Therapeutics ·Robert Ruffolo, Robert D. Dillard, E L Yaden, J E Waddell	1979	23
15	Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor. Journal of Pharmacology and Experimental Therapeutics ·J H Fleisch, Christopher T. Armstrong, (unknown), Edward D. Mihelich, Stephen M. Spaethe, William T. Jackson, Jesse L. Bobbitt, Susan E. Draheim, Nicholas J. Bach, Robert D. Dillard, Marcella Martinelli, R Fouts, David W. Snyder	1996	19
16	Leukotriene receptor antagonists. 2. The [[(tetrazol-5-ylaryl)oxy]methyl]acetophenone derivatives Journal of Medicinal Chemistry ·Robert D. Dillard, F. Patrick Carr, Doris McCullough, Klaus D. Haisch, Lynn E. Rinkema, Jerome H. Fleisch	1987	17
17	Synthesis of 3-substituted 1,4-pentadiyn-3-ols The Journal of Organic Chemistry ·Robert D. Dillard, D. E. Pavey	1971	15
18	Evaluation of LY163443, 1-[2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-ylmethyl)phenoxy]methyl}phenyl]ethanone, as a pharmacologic antagonist of leukotrienes D4 and E4 Naunyn-Schmiedeberg s Archives of Pharmacology ·Jerome H. Fleisch, Lynn E. Rinkema, Klaus D. Haisch, Doris McCullough, F. Patrick Carr, Robert D. Dillard	1986	13
19	Acetylenic Amines. XII. Some New Reactions of Acylaminoacetylenes The Journal of Organic Chemistry ·Nelson R. Easton, Donald R. Cassady, Robert D. Dillard	1965	13
20	Receptor interactions of imidazolines. III. Structure-activity relationships governing alpha adrenergic receptor occupation and receptor activation for mono- and dimethoxy-substituted tolazoline derivatives in rat aorta. Journal of Pharmacology and Experimental Therapeutics ·Robert Ruffolo, Robert D. Dillard, J E Waddell, E L Yaden	1979	11

About Robert D. Dillard

Robert D. Dillard is a scholar working on Organic Chemistry, Molecular Biology, Pharmaceutical Science, Pulmonary and Respiratory Medicine and Physiology, having authored 39 papers that have together received 980 indexed citations. Recurring topics across this work include Fluorine in Organic Chemistry (8 papers), Synthesis and Reactions of Organic Compounds (7 papers), Protein Kinase Regulation and GTPase Signaling (7 papers), Synthesis of heterocyclic compounds (5 papers), Synthesis and Characterization of Pyrroles (5 papers), Chemical Synthesis and Analysis (4 papers), Carbohydrate Chemistry and Synthesis (4 papers) and Asymmetric Synthesis and Catalysis (3 papers). The work is most often cited by research in Organic Chemistry (406 citations), Molecular Biology (489 citations), Pharmacology (97 citations), Cancer Research (69 citations) and Biochemistry (28 citations). Robert D. Dillard has collaborated with scholars based in United States. Frequent co-authors include Nelson R. Easton, Nicholas J. Bach, David W. Snyder, Susan E. Draheim, Lawrence W. Hartley, Edward D. Mihelich, Cynthia D. Sommers, Richard W. Schevitz, David K. Clawson and Jennifer L. Olkowski. Their work appears in journals such as The Journal of Organic Chemistry, Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics, Toxicology and Applied Pharmacology and Tetrahedron Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact